ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,281.22
0.08%
Dow Jones
44,722.06
-0.31%
Gold vs US Dollar
2,637.60
0.02%
Brent Oil
72.675
0.39%
Bitcoin
95,104.69
-0.91%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Universe Pharmaceuticals Inc (UPC)

  7. Universe Pharmaceuticals Inc (UPC) News

Universe Pharmaceuticals (UPC)

Universe Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:UPC
DateTimeSourceHeadlineSymbolCompany
13/11/202413:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
13/11/202413:00GlobeNewswire Inc.Universe Pharmaceuticals INC Announces Share ConsolidationNASDAQ:UPCUniverse Pharmaceuticals Inc
01/11/202420:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
01/11/202420:00GlobeNewswire Inc.Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price DeficiencyNASDAQ:UPCUniverse Pharmaceuticals Inc
10/10/202420:10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
27/09/202420:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
20/09/202420:15GlobeNewswire Inc.Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2024NASDAQ:UPCUniverse Pharmaceuticals Inc
20/09/202420:15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
03/09/202420:10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
18/07/202420:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
10/06/202404:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:UPCUniverse Pharmaceuticals Inc
14/05/202420:06Edgar (US Regulatory)Form F-1/A - Registration statement for certain foreign private issuers: [Amend]NASDAQ:UPCUniverse Pharmaceuticals Inc
07/02/202413:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
30/01/202421:30PR Newswire (US)Universe Pharmaceuticals INC Reports Fiscal Year 2023 Financial ResultsNASDAQ:UPCUniverse Pharmaceuticals Inc
30/01/202417:05Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:UPCUniverse Pharmaceuticals Inc
31/08/202320:10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
16/08/202320:10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
04/08/202312:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
04/08/202312:30GlobeNewswire Inc.Universe Pharmaceuticals INC Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Publicly Held SharesNASDAQ:UPCUniverse Pharmaceuticals Inc
27/07/202320:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
27/07/202314:15GlobeNewswire Inc.Universe Pharmaceuticals INC Announces Share ConsolidationNASDAQ:UPCUniverse Pharmaceuticals Inc
05/07/202320:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
24/05/202320:30Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:UPCUniverse Pharmaceuticals Inc
05/05/202320:16Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:UPCUniverse Pharmaceuticals Inc
07/03/202313:00GlobeNewswire Inc.Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price DeficiencyNASDAQ:UPCUniverse Pharmaceuticals Inc
14/02/202319:15Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:UPCUniverse Pharmaceuticals Inc
10/02/202321:58Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:UPCUniverse Pharmaceuticals Inc
21/12/202213:00GlobeNewswire Inc.Universe Pharmaceuticals INC Announces Inclusion of Six Products into the First Edition of Catalogue of Medicine for Patients Infected with COVID-19NASDAQ:UPCUniverse Pharmaceuticals Inc
14/11/202213:03Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:UPCUniverse Pharmaceuticals Inc
14/11/202213:00GlobeNewswire Inc.Universe Pharmaceuticals INC Regains Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:UPCUniverse Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:UPC

Your Recent History

LSE
VAST
Vast Resources
LSE
POS
Plexus
LSE
SYME
Supply@me Capital
LSE
DLG
Direct Line Insurance
LSE
GKP
Gulf Keystone Petroleum
LSE
THG
Thg
LSE
OPTI
Optibiotix Health
LSE
DEC
Diversified Energy
LSE
BOO
Boohoo
LSE
MIN
Minoan
LSE
GDR
Genedrive
LSE
BIRD
Blackbird
LSE
SCLP
Scancell
LSE
AAZ
Anglo Asian Mining
LSE
GBP
Global Petroleum
LSE
AV.
Aviva
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 60%* for Level 2 Lite

    1 year 35%, 2 years 45% and *3 years 60%

    *Across 3 years £2132.64 only £853.06